Skip to content

L-carnitine and Metformin in Obese PCOS Women.

L-carnitine Plus Metformin in Clomiphene-resistant Obese PCOS Women, Reproductive and Metabolic Effects: a Randomized Clinical Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03108963
Enrollment
280
Registered
2017-04-11
Start date
2017-01-31
Completion date
2018-03-31
Last updated
2018-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Brief summary

L-carnitine and plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effect: a randomized clinical trial

Detailed description

the trial aims to compare L-carnitine and plus metformin in clomiphene-resistant obese PCOS women with placebo to state the reproductive and metabolic effects in form of pregnancy and insulin resistance parameters and lipid metabolism.

Interventions

DRUGL-carnitine and Metformin

L-carnitine plus Metformin was given Obese PCOS Women trying induction of ovulation with clomiphene citrate.

DRUGplacebo

placebo was given Obese PCOS Women trying induction of ovulation with clomiphene citrate.

Sponsors

Zagazig University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* pco * obese * ifertile

Exclusion criteria

* no medical disorders * no hormonal treatment in the previous 3 months

Design outcomes

Primary

MeasureTime frameDescription
pregnancy rate3 momthsnumber of women with clinical pregnancy

Secondary

MeasureTime frameDescription
ovulation rate3 momthsnumber of women with follicle \>18mm.
abortion rate3 momthsnumber of women with abortions
insulin resistance3 momthsfasting glucose and insulin
lipid metabolism3 momthsTriglyceride, cholesterol

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026